Quest PharmaTech Inc. (QPT.V)
TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous Close | 0.0800 |
| Open | 0.0950 |
| Bid | 0.0800 x 0 |
| Ask | 0.0950 x 0 |
| Day's Range | 0.0950 - 0.0950 |
| 52 Week Range | 0.0600 - 0.1700 |
| Volume | |
| Avg. Volume | 15,195 |
| Market Cap | 16.048M |
| Beta (5Y Monthly) | 1.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5050 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jul 21, 2005 |
| 1y Target Est | N/A |
- CNW Group
Quest PharmaTech Announces Results from AGM
Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the results of its July 19, 2022 annual general meeting of shareholders.
- CNW Group
Quest PharmaTech Provides Corporate Update
Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that it has borrowed $1 million of working capital funding from one of its investee companies, OncoQuest Inc.
- CNW Group
OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian Cancer
OncoQuest Pharmaceuticals Inc., ("OncoQuest") a clinical-stage biopharmaceutical company focused on the development and commercialization of immunotherapies for cancer, today announces the first patient enrolled in each of two investigator initiated clinical trials assessing the safety and efficacy of oregovomab in a previously treated recurrent ovarian cancer setting.
© 2022 Yahoo. All rights reserved.
